Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A Craig

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humansPaul G Ambrose, George L Drusano, William A Craig
Clinics in Laboratory Medicine|June 5, 2004
Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infectionsDavid Andes, Jack Anon, Michael R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic miceDong-Gun Lee, Yoichi Murakami, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection modelAlexander J Lepak, Karen Marchillo, William A Craig, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2012
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia modelAlexander J Lepak, Karen Marchillo, Solen Pichereau, et al.
Clinical Therapeutics|December 28, 2002
A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group studyCharles M Fogarty, Marcia Cyganowski, William A Palo, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamasesRonald N Jones, William A Craig, Paul G Ambrose, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2007
Tissue concentrations: do we ever learn?Johan W Mouton, Ursula Theuretzbacher, William A Craig, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2008
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic modelsKerry L LaPlante, Steven N Leonard, David R Andes, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2006
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance ProgramSujata M Bhavnani, Paul G Ambrose, William A Craig, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humansPaul G Ambrose, George L Drusano, William A Craig
Clinics in Laboratory Medicine|June 5, 2004
Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infectionsDavid Andes, Jack Anon, Michael R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic miceDong-Gun Lee, Yoichi Murakami, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection modelAlexander J Lepak, Karen Marchillo, William A Craig, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2012
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia modelAlexander J Lepak, Karen Marchillo, Solen Pichereau, et al.
Clinical Therapeutics|December 28, 2002
A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group studyCharles M Fogarty, Marcia Cyganowski, William A Palo, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamasesRonald N Jones, William A Craig, Paul G Ambrose, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2007
Tissue concentrations: do we ever learn?Johan W Mouton, Ursula Theuretzbacher, William A Craig, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2008
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic modelsKerry L LaPlante, Steven N Leonard, David R Andes, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2006
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance ProgramSujata M Bhavnani, Paul G Ambrose, William A Craig, et al.
Pageof 4